ASMB — ASSEMBLY BIOSCIENCES INC

Ownership history in Frazier Life Sciences Management, L.P.  ·  1 quarter on record

This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in ASSEMBLY BIOSCIENCES INC (ASMB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.35% (2025 Q3)
Avg. % of fund
0.35%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 456,249 — — 0.35% $11.7M $25.60
% of Fund (quarterly)    ASMB price (monthly, adj. close)

Other funds also holding ASMB

As of 2025 Q4 — sorted by position size

GILEAD SCIENCES, INC. 7.92% B Group, Inc. 4.41% Commodore Capital LP 3Y 2.26% SUPERSTRING CAPITAL MANAGEMENT LP 1.19% Patient Square Capital LP 3Y 0.92% STEMPOINT CAPITAL LP 0.91% MONIMUS CAPITAL MANAGEMENT, LP 0.86% Parkman Healthcare Partners LLC 3Y 0.81% Paradigm Biocapital Advisors LP 3Y 0.58% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 0.36%
← Back to Frazier Life Sciences Management, L.P. Holdings